Inventor · disambiguated record
Shimon Slavin
Also filed as: GUREVITCH OLGA · SLAVIN SHIMON
30 granted patents·12 pending applications·578 citations·filing 1992–2021
97Inventor score
Files withHADASIT MED RES SERVICE9SLAVIN SHIMON4AGRICULTURAL RES ORG3BRAINSTEM BIOTEC LTD3BEN-GURION UNIV OF THE NEGEV RES AND DEV AUTHORITY2
Top patents by PatentIndex Score
42 records- 0190US5449678AAnti-fibrotic quinazolinone-containing compositions and methods for the use thereofAGRICULTURAL RES ORG·Filed 1994·Granted Sep 12, 1995·113 cites·6 claims
- 0286US8071641B2Treating or preventing diabetes with cannabidiolWEISS LOLA·Filed 2005·Granted Dec 6, 2011·28 cites·5 claims
- 0384US6143292AAllogeneic cell therapy for cancer following allogeneic stem cell transplantationBAXTER INT·Filed 1996·Granted Nov 7, 2000·60 cites·16 claims
- 0482US8609736B2Telomerase activating compounds and methods of use thereofGAZIT AVIV·Filed 2008·Granted Dec 17, 2013·7 cites·13 claims
- 0582US8604245B2Tri-aryl compounds and compositions comprising the samePRIEL ESTHER·Filed 2008·Granted Dec 10, 2013·7 cites·10 claims
- 0682US6159488AIntracoronary stents containing quinazolinone derivativesAGRICULTURAL RES ORG MINISTRY·Filed 1999·Granted Dec 12, 2000·88 cites·2 claims
- 0781US6447767B1Non-myeloablative tolerogenic treatmentHADASIT MED RES SERVICE·Filed 2000·Granted Sep 10, 2002·17 cites·16 claims
- 0878US8066989B2Method of treating tumor growth and metastasis by using trifunctional antibodies to reduce the risk for GvHD in allogeneic antitumor cell therapyLINDHOFER HORST·Filed 2004·Granted Nov 29, 2011·9 cites·15 claims
- 0977US9663448B2Tri-aryl compounds and compositions comprising the sameBEN-GURION UNIV OF THE NEGEV RES AND DEV AUTHORITY·Filed 2013·Granted May 30, 2017·2 cites·4 claims
- 1076US6544787B1Non-myeloablative/lymphoablative conditioning regimen to induce patient anti-donor unresponsiveness in stem cell transplantationHADASH MEDICAL RES SERVICES AN·Filed 1997·Granted Apr 8, 2003·46 cites·27 claims
- 1176US5891879AQuinazolinone-containing pharmaceutical compositions and methods for the use thereofHADASIT MED RES SERVICE·Filed 1995·Granted Apr 6, 1999·46 cites·7 claims
- 1275US9670139B2Telomerase activating compounds and methods of use thereofBEN-GURION UNIV OF THE NEGEV RES AND DEV AUTHORITY·Filed 2013·Granted Jun 6, 2017·2 cites·5 claims
- 1374US5928639AImmunotherapy of cancer with allogeneic lymphocytesHADASIT MED RES SERVICE·Filed 1996·Granted Jul 27, 1999·34 cites·18 claims
- 1472US9803175B2Generation of neural stem cells and motor neuronsBRAINSTEM BIOTEC LTD·Filed 2013·Granted Oct 31, 2017·2 cites·4 claims
- 1570US5461034AOsteogenic growth polypeptides identified from regenerating bone marrowYISSUM RES DEV CO·Filed 1993·Granted Oct 24, 1995·44 cites·19 claims
- 1669US5843435AImmunotherapy of cancer with allogeneic lymphocytesHADASIT MED RES SERVICE·Filed 1995·Granted Dec 1, 1998·22 cites·22 claims
- 1765US10034902B2MicroRNAs for the generation of astrocytesBRAINSTEM BIOTEC LTD·Filed 2013·Granted Jul 31, 2018·1 cites·9 claims
- 1865US9783781B2Methods of generating oligodendrocytes and cell populations comprising sameSLAVIN SHIMON·Filed 2011·Granted Oct 10, 2017·1 cites·4 claims
- 1959US8741315B2Methods of treating tumors in immune-privileged sitesVOLOVITZ ILAN·Filed 2008·Granted Jun 3, 2014·0 cites·15 claims
- 2057US2002176850A1Immunotherapy of cancer with allogeneic lymphocytesFiled 2001·Application pending·0 cites
- 2155US6428782B1Non-myeloablative tolerogenic treatmentHADASIT MED RES SERVICE·Filed 1998·Granted Aug 6, 2002·14 cites·9 claims
- 2254US9340488B2Synthetic analogs of sphingolipidsHADASIT MED RES SERVICE·Filed 2014·Granted May 17, 2016·0 cites·4 claims
- 2354US2010158973A1Therapeutic uses of cannabidiol compoundsHADASIT MED RES SERVICE·Filed 2007·Application pending·0 cites
- 2453US7347999B2Methods of treatment of hematopoietic disordersSLAVIN SHIMON·Filed 2002·Granted Mar 25, 2008·1 cites·8 claims
- 2553US2024299476A1Use of a birnavirus alone or in combination therapy for the treatment of cancerPROBIOGEN AG·Filed 2021·Application pending·0 cites
- 2652US6090814AQuinazolinone-containing pharmaceutical compositions for prevention of neovascularizationAGRICULTURAL RES ORG·Filed 1996·Granted Jul 18, 2000·14 cites·2 claims
- 2751US8962891B2Synthetic analogs of sphingolipidsDAGAN ARIE·Filed 2008·Granted Feb 24, 2015·0 cites·11 claims
- 2851US2020063135A1Methods, systems, and compositions for neuronal differentiation of multipotent stromal cellsEXOSTEM BIOTEC LTD·Filed 2019·Application pending·0 cites
- 2947US2007264240A1Compositions comprising bone marrow cells together with demineralized and/or mineralized bone matrix and uses thereof in the induction of bone and cartilage formationHADASIT MED RES SERVICE·Filed 2007·Application pending·0 cites
- 3046US2024024390A1Use of a birnavirus alone or in combimation therapy for the treatment of a disease caused by a nidovirusPROBIOGEN AG·Filed 2020·Application pending·0 cites
- 3145US2006177387A1Compositions comprising bone marrow cells, demineralized bone matrix and various site-reactive polymers for use in the induction of bone and cartilage formationSLAVIN SHIMON·Filed 2003·Application pending·0 cites
- 3244US5594005AUse of quinoline-3-carboxamide compounds for treatment of diabetesPHARMACIA AB·Filed 1993·Granted Jan 14, 1997·6 cites·9 claims
- 3343US2008213332A1Cells Isolated from Placenta, Device for Isolating Same, and Uses ThereofSLAVIN SHIMON·Filed 2005·Application pending·0 cites
- 3443US2010311841A1Synthetic sphingolipid analogsDAGAN ARIE·Filed 2008·Application pending·0 cites
- 3542US10421961B2Methods, systems, and compositions for neuronal differentiation of multipotent stromal cellsBRODIE CHAYA·Filed 2010·Granted Sep 24, 2019·0 cites·6 claims
- 3640US5866546ATreatment for diabetesHADASIT MED RES SERVICE·Filed 1997·Granted Feb 2, 1999·4 cites·3 claims
- 3738US9283199B2Halogenated aliphatic carboxylic acids, oligomers and/or polymers thereof and their use in devitalizing external and internal neoplasmsMARDI SHALVA·Filed 2010·Granted Mar 15, 2016·0 cites·14 claims
- 3838US2015024966A1Mesenchymal stem cells for in vitro modeling and cell-based therapy of human diseases and banks thereofBRAINSTEM BIOTEC LTD·Filed 2013·Application pending·0 cites
- 3938US2016067198A1Halogenated aliphatic carboxylic acids, oligomers and/or polymers thereof and their use in devitalizing external and internal neoplasmsCIMAS LTD·Filed 2015·Application pending·0 cites
- 4037US2004197335A1Non-myeloablative tolerogenic treatment with tyrphostinsFiled 2002·Application pending·0 cites
- 4134US5998422AQuinazolinone-containing pharmaceutical compositions and methods for the use thereofAGRICULTURAL RES ORG·Filed 1995·Granted Dec 7, 1999·2 cites·2 claims
- 4234US5580882AUse of substituted quinoline carboxamideKABI PHARMACIA AB·Filed 1992·Granted Dec 3, 1996·8 cites·2 claims
Join the waitlist — get patent alerts
Get an alert when Shimon Slavin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →